hair loss semaglutide side effects GLP-1 Loss: How Wegovy, Ozempic & Mounjaro Cause Thinning (And Ho Ozempic Hair Loss: What You

Anyone using oral contraceptives or other hormonal treatments should discuss this with their healthcare professional to ensure their treatment remains suitable

One of the largest retrospective studies to date, by Villumsen et al., 89 utilized Danish national registry data from 2007 to 2019 to assess 3751 patients with IBD (77.5% UC, 22.5% CD) and T2DM

Using western blotting, we found that the protein levels of c-fos in the TNC in the CM (1.13 0.14) and exendin(939) treated group (1.08 0.20) were significantly upregulated (Fig

theres so much more to come with Rivs

Individuals with T2DM frequently have multiple cardiovascular risk factors, including obesity (32.9%), hypertension (32-80%), and dyslipidemia (39%) ( The association between glycemic control and cardiovascular outcomes in DM patients has been long studied ( To address these challenges, novel pharmacological therapies such as sodium-glucose cotransporter-2 inhibitors (SGLT-2i) and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have emerged, offering cardioprotective benefits ( The aim of this review is to enhance our understanding of the role of SGLT-2i and GLP-1 RAs in managing patients with T2DM and CVD